Peptidomimetic compound as well as preparation method, pharmaceutical composition and application thereof
The invention relates to a peptidomimetic compound as well as a preparation method, a pharmaceutical composition and application thereof. Specifically, the invention discloses a peptidomimetic compound as shown in a general formula (I), or a raceme, a cis-trans-isomer, an enantiomer, a diastereoisom...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a peptidomimetic compound as well as a preparation method, a pharmaceutical composition and application thereof. Specifically, the invention discloses a peptidomimetic compound as shown in a general formula (I), or a raceme, a cis-trans-isomer, an enantiomer, a diastereoisomer or a mixture thereof, or a metabolite, or a pharmaceutically acceptable salt, a solvate or a prodrug, the invention also discloses an application of the compound in inhibition of coronaviruses such as SARS-CoV-2, SARS-CoV, MERS-CoV and the like, and other RNA viruses such as EV71, EV68, norovirus and the like.
本发明涉及一种拟肽类化合物及其制备方法、药物组合物和用途。具体地,本发明公开了一种通式(I)所示的拟肽类化合物、或其外消旋体、顺反异构体、对映异构体、非对映异构体或它们的混合物,或其代谢物,或其药学上可接受的盐、溶剂化物或前药;本发明还公开了所述化合物在抑制包括SARS-CoV-2、SARS-CoV、MERS-CoV等冠状病毒,以及其他如EV71、EV68、诺如病毒等RNA病毒方面的应用。 |
---|